Epithelial Ovarian Cancer

• FDA approval · 2022-11-14
  FDA Approved: ELAHERE — Original Application (ImmunoGen, Inc.)

  The FDA approved ELAHERE (mirvetuximab soravtansine) from ImmunoGen as the original approval for FRα-positive, platinum-resistant epithelial…

• FDA approval · 2019-06-27
  FDA Approved: ZIRABEV — Original Application (Pfizer Laboratories Div Pfizer Inc)

  FDA approves ZIRABEV (bevacizumab-bvzr) from Pfizer as a biosimilar to Avastin under an Original Application. The approval covers multiple b…

• FDA approval · 2017-09-14
  FDA Approved: MVASI — Original Application (Amgen, Inc)

  The FDA approved MVASI (bevacizumab-awwb) from Amgen as a biosimilar to Avastin, marking the original application granting U.S. approval for…